114 related articles for article (PubMed ID: 23740395)
1. Homology modeling of LmxMPK4 of Leishmania mexicana and virtual screening of potent inhibitors against it.
Gupta CL; Khan MK; Khan MF; Tiwari AK
Interdiscip Sci; 2013 Jun; 5(2):136-44. PubMed ID: 23740395
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase 4 of Leishmania parasite as a therapeutic target.
Saravanan P; Venkatesan SK; Mohan CG; Patra S; Dubey VK
Eur J Med Chem; 2010 Dec; 45(12):5662-70. PubMed ID: 20884088
[TBL] [Abstract][Full Text] [Related]
3. LmxMPK4, an essential mitogen-activated protein kinase of Leishmania mexicana is phosphorylated and activated by the STE7-like protein kinase LmxMKK5.
John von Freyend S; Rosenqvist H; Fink A; Melzer IM; Clos J; Jensen ON; Wiese M
Int J Parasitol; 2010 Jul; 40(8):969-78. PubMed ID: 20178803
[TBL] [Abstract][Full Text] [Related]
4. In Silico Elucidation and Inhibition Studies of Selected Phytoligands Against Mitogen-Activated Protein Kinases of Protozoan Parasites.
Gupta CL; Akhtar S; Kumar N; Ali J; Pathak N; Bajpai P
Interdiscip Sci; 2016 Mar; 8(1):41-52. PubMed ID: 26264054
[TBL] [Abstract][Full Text] [Related]
5. Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors.
Awale M; Kumar V; Saravanan P; Mohan CG
J Mol Model; 2010 Mar; 16(3):475-88. PubMed ID: 19649663
[TBL] [Abstract][Full Text] [Related]
6. Interactions of antiparasitic alkaloids with Leishmania protein targets: a molecular docking analysis.
Ogungbe IV; Ng JD; Setzer WN
Future Med Chem; 2013 Oct; 5(15):1777-99. PubMed ID: 24144413
[TBL] [Abstract][Full Text] [Related]
7. Homology modeling, docking and molecular dynamics of the Leishmania mexicana arginase: a description of the catalytic site useful for drug design.
Méndez-Cuesta CA; Méndez-Lucio O; Castillo R
J Mol Graph Model; 2012 Sep; 38():50-9. PubMed ID: 23085157
[TBL] [Abstract][Full Text] [Related]
8. LmxPK4, a mitogen-activated protein kinase kinase homologue of Leishmania mexicana with a potential role in parasite differentiation.
Kuhn D; Wiese M
Mol Microbiol; 2005 Jun; 56(5):1169-82. PubMed ID: 15882412
[TBL] [Abstract][Full Text] [Related]
9. Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification.
Ke YY; Singh VK; Coumar MS; Hsu YC; Wang WC; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Shih C; Hsieh HP
Sci Rep; 2015 Jun; 5():11702. PubMed ID: 26118648
[TBL] [Abstract][Full Text] [Related]
10. LmxMPK4, a mitogen-activated protein (MAP) kinase homologue essential for promastigotes and amastigotes of Leishmania mexicana.
Wang Q; Melzer IM; Kruse M; Sander-Juelch C; Wiese M
Kinetoplastid Biol Dis; 2005 Dec; 4():6. PubMed ID: 16384531
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel anti-leishmanial agents targeting LdLip3 lipase.
Parameswaran S; Saudagar P; Dubey VK; Patra S
J Mol Graph Model; 2014 Apr; 49():68-79. PubMed ID: 24530543
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of leishmanial protein kinase by antileishmanial drugs.
Berman JD
Am J Trop Med Hyg; 1988 Mar; 38(2):298-303. PubMed ID: 2833126
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling, structural analysis and identification of ligand binding sites of trypanothione reductase from Leishmania mexicana.
Mutlu O
J Vector Borne Dis; 2013 Mar; 50(1):38-44. PubMed ID: 23703438
[TBL] [Abstract][Full Text] [Related]
14. Screening natural products database for identification of potential antileishmanial chemotherapeutic agents.
Venkatesan SK; Saudagar P; Shukla AK; Dubey VK
Interdiscip Sci; 2011 Sep; 3(3):217-31. PubMed ID: 21956744
[TBL] [Abstract][Full Text] [Related]
15. Identification of mitogen-activated protein kinase homologues from Leishmania mexicana.
Wiese M; Wang Q; Görcke I
Int J Parasitol; 2003 Dec; 33(14):1577-87. PubMed ID: 14636673
[TBL] [Abstract][Full Text] [Related]
16. The crystal structure of the MAP kinase LmaMPK10 from Leishmania major reveals parasite-specific features and regulatory mechanisms.
Horjales S; Schmidt-Arras D; Limardo RR; Leclercq O; Obal G; Prina E; Turjanski AG; Späth GF; Buschiazzo A
Structure; 2012 Oct; 20(10):1649-60. PubMed ID: 22884419
[TBL] [Abstract][Full Text] [Related]
17. Benzimidazole Derivatives as New and Selective Inhibitors of Arginase from
Betancourt-Conde I; Avitia-Domínguez C; Hernández-Campos A; Castillo R; Yépez-Mulia L; Oria-Hernández J; Méndez ST; Sierra-Campos E; Valdez-Solana M; Martínez-Caballero S; Hermoso JA; Romo-Mancillas A; Téllez-Valencia A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948408
[TBL] [Abstract][Full Text] [Related]
18. A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host.
Wiese M
EMBO J; 1998 May; 17(9):2619-28. PubMed ID: 9564044
[TBL] [Abstract][Full Text] [Related]
19. Homologues of LMPK, a mitogen-activated protein kinase from Leishmania mexicana, in different Leishmania species.
Wiese M; Görcke I
Med Microbiol Immunol; 2001 Nov; 190(1-2):19-22. PubMed ID: 11770102
[TBL] [Abstract][Full Text] [Related]
20.
Matadamas-Martínez F; Hernández-Campos A; Téllez-Valencia A; Vázquez-Raygoza A; Comparán-Alarcón S; Yépez-Mulia L; Castillo R
Molecules; 2019 Sep; 24(18):. PubMed ID: 31487860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
